Xenon News and Research RSS Feed - Xenon News and Research

Xenon collaborates with Genentech to develop new therapeutic targets for treating pain

Xenon collaborates with Genentech to develop new therapeutic targets for treating pain

Xenon Pharmaceuticals Inc. today announced the establishment of a new collaboration with Genentech, a member of the Roche Group, for pain genetics, with the goal of discovering and validating new therapeutic targets and mechanisms for treating pain. [More]
UCLA researchers find no evidence of association between iron levels and atherosclerosis risk

UCLA researchers find no evidence of association between iron levels and atherosclerosis risk

A UCLA research team has found no evidence of an association between iron levels in the body and the risk of atherosclerosis, the hardening and narrowing of the arteries that leads to cardiovascular disease, the No. 1 killer in the U.S. [More]
Infection prevention: an interview with Dr. Robert Gorab, Chief Medical Officer, Hoag Orthopedic Institute

Infection prevention: an interview with Dr. Robert Gorab, Chief Medical Officer, Hoag Orthopedic Institute

HOI has one of the lowest if not the lowest surgical readmission rate in the State of California. Our all-cause readmission rate is 3.3% and our joint replacement readmission was at 1.8% based on published CMS reports we received in September 2013. [More]
Recanalization of extracranial internal carotid artery occlusion: A retrospective study

Recanalization of extracranial internal carotid artery occlusion: A retrospective study

Carotid endarterectomy can benefit the majority of patients with severe carotid artery stenosis. However, the therapeutic effects of this technique in patients with symptomatic internal carotid artery occlusion remain controversial. [More]
New UV-visible spectrophotometer released by Hitachi High Technologies America, Inc.

New UV-visible spectrophotometer released by Hitachi High Technologies America, Inc.

The Life Sciences Division of Hitachi High Technologies America, Inc. released its newest UV-visible spectrophotometer, Model UH5300. [More]
Decatur Memorial Hospital installs germ-zapping robots to kill bugs

Decatur Memorial Hospital installs germ-zapping robots to kill bugs

As hospitals across the nation look for new and innovative ways to battle deadly pathogens and kill multi-drug resistant organisms that put patients at risk, Decatur Memorial Hospital (DMH) has taken a leap into the future with the installation of two germ-zapping robots that eliminate hard-to-kill bugs in hard-to-clean places. [More]

FDA grants orphan-drug designation to XEN402 for treatment of pain associated with EM

Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals Inc. announced today that the US Food and Drug Administration has granted orphan-drug designation to the investigational drug XEN402 being developed for the treatment of pain associated with erythromelalgia. [More]
Xenon Pharmaceuticalsn receives BIOTECanada's Gold Leaf Company of the Year Award for 2013

Xenon Pharmaceuticalsn receives BIOTECanada's Gold Leaf Company of the Year Award for 2013

Xenon Pharmaceuticals Inc. is pleased to announce that it has been awarded BIOTECanada's Gold Leaf Company of the Year Award for 2013. [More]

Pelchem and Linde team up to advance MEMS systems

Linde Electronics, the global electronics business of The Linde Group, has strengthened its material support for electronics manufacturing by announcing a strategic partnership with Pelchem, the global fluorochemicals specialist, to accelerate the development of Micro-Electro-Mechanical Systems (MEMS). [More]
BMBF to provide EUR 1.3M to develop MRI using polarized substances

BMBF to provide EUR 1.3M to develop MRI using polarized substances

Over the past 30 years, magnetic resonance imaging has evolved into one of the most important imaging procedures in medical diagnostics. With a new approach based on the use of polarized gases and dissolved substances, it will in future be possible to produce even better quality images of the inside of the human body. [More]
WellStar Health System implements Xenex’s room disinfection system

WellStar Health System implements Xenex’s room disinfection system

WellStar Health System was the first to implement and is the only health system in metro-Atlanta using Xenex Healthcare Services' room disinfection system in its patient and operating rooms. A "green," mercury-free technology, the Xenex system is the fastest, safest and most effective method for the advanced cleaning of hospital rooms, scientifically proven to destroy all major classes of microorganisms that cause hospital acquired infections (HAIs), such as MRSA and Clostridium difficile (C. diff). [More]

Xenex offers room disinfection devices to hospitals hit by Hurricane Sandy

Xenex Healthcare Services, the world leader in UV room disinfection systems, today announced it is making its room disinfection devices available to hospitals affected by Hurricane Sandy. [More]

Xenex Healthcare Services receives GSA contract to purchase room disinfection systems

Xenex Healthcare Services, the world leader in UV room disinfection systems, today announced it has been awarded a U.S. General Services Administration (GSA) contract, making it even easier for federal agencies (including Veterans Affairs hospital systems) to purchase Xenex's room disinfection systems. [More]
Xenex's pulsed xenon UV more effective than bleach in decontaminating C. diff surfaces

Xenex's pulsed xenon UV more effective than bleach in decontaminating C. diff surfaces

Healthcare associated infections (also referred to as HAIs or hospital acquired infections) are the fourth leading cause of death in the United States, costing more than $30 billion each year. Evidence continues to mount that hospital cleanliness plays a role in the spread of HAIs, which are caused by deadly pathogens such as C. diff, MRSA, VRE and Acinetobacter. [More]
Super-bug technology draws high-tech attention

Super-bug technology draws high-tech attention

The Centers for Medicare & Medicaid Services has said 2012 will be the year that hospitals should start paying to treat infections contracted on their premises. Many investors have the issue pegged as a janitorial concern, and not necessarily the purview of high-tech gadgets. [More]

MountainView Hospital first in Nevada to use Xenex’s room disinfection device

In an ongoing effort to improve patient safety, MountainView Hospital today announced it is the first hospital in Nevada to use Xenex Healthcare Services' innovative germ-zapping room disinfection technology to keep patients even safer from infections. [More]

Energetiq launches EQ-99CAL laser-driven light source

Energetiq Technology, Inc., a developer and manufacturer of ultrahigh-brightness, broadband light sources for advanced technology applications, today introduced a new light source to its established line of LDLS Laser-Driven Light Sources for use in radiometric calibration. [More]

Genentech, Xenon partner to discover and develop novel pain relieving medicines

Xenon today announced a strategic alliance with Genentech, a member of the Roche Group, to discover and develop compounds and companion diagnostics for the potential treatment of pain. [More]

Premier awards Lantheus three-year supplier agreement for nuclear imaging products

Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced it has been awarded a three-year supplier contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, for its radiopharmaceutical imaging agents. [More]

Cone Health uses Xenex room disinfection systems to reduce HAI rates and costs

Cone Health today announced a dramatic reduction in healthcare-acquired infection (HAIs) rates after implementing an infection prevention program which includes Xenex room disinfection systems. [More]